AB
MBII

Amalgamated Bank’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Amalgamated Bank’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-16,485
Closed -$18K – 3320
2022
Q1 		$18K Sell
16,485
-1,334
-7% -$1.01K ﹤0.01% 2842
2021
Q4 		$13K Sell
17,819
-490
-3% -$396 ﹤0.01% 2155
2021
Q3 		$16K Sell
18,309
-611
-3% -$735 ﹤0.01% 2160
2021
Q2 		$31K Buy
18,920
+8,703
+85% +$14.5K ﹤0.01% 2177
2021
Q1 		$21K Hold
10,217
– – ﹤0.01% 1597
2020
Q4 		$13K Hold
10,217
– – ﹤0.01% 1586
2020
Q3 		$12K Sell
10,217
-33
-0.3% -$40 ﹤0.01% 1491
2020
Q2 		$12K Buy
+10,250
New +$9.48K ﹤0.01% 1480

Other funds holding MBII

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

Amalgamated Bank's MBII Position: Q2 2022 in Review

Amalgamated Bank sold out of Marrone Bio Innovations, Inc. (MBII) in Q2 2022, closing a stake of 16,485 shares — an estimated $18K sold.

Amalgamated Bank first reported a position in MBII in Q2 2020 and held it in 8 quarters. The position peaked at $31K in Q2 2021. 62 funds tracked by Wall St. Rank hold MBII as of Q2 2022.

  • Amalgamated Bank reported no remaining Marrone Bio Innovations, Inc. position as of Q2 2022 after selling out during the quarter.
  • Amalgamated Bank sold 16,485 Marrone Bio Innovations, Inc. shares in Q2 2022, an estimated $18K.
  • Amalgamated Bank first reported a position in Marrone Bio Innovations, Inc. in Q2 2020 and held it in 8 quarters.
  • Amalgamated Bank's Marrone Bio Innovations, Inc. position peaked at $31K in Q2 2021.
  • 62 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q2 2022.

Based on Amalgamated Bank's 13F filing for Q2 2022, filed 15 Aug 2022.